Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOPs for Capsules V 2.0

Capsule: SOP for Shelf-Life Prediction Studies for Capsules – V 2.0

Posted on By

The purpose of this SOP is to define the procedure for conducting shelf-life prediction studies for capsules. These studies are critical in determining the stability and expiry date of capsules, ensuring their effectiveness, safety, and compliance with regulatory standards over time.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Validation of Capsule Development Procedures – V 2.0

Posted on By

The purpose of this SOP is to establish a systematic approach for validating capsule development procedures. It ensures that all processes related to capsule formulation, filling, and sealing are performed under controlled conditions and meet regulatory and quality standards.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Formulating High-Potency Drugs in Capsules – V 2.0

Posted on By

The purpose of this SOP is to establish a consistent procedure for formulating high-potency drugs in capsules. High-potency drugs require special handling and formulation techniques due to their small therapeutic dose and potential risk to personnel during production.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Designing Extended-Release Capsule Formulations – V 2.0

Posted on By

The purpose of this SOP is to outline the procedure for designing extended-release (ER) capsule formulations. The aim is to develop capsules that provide a controlled release of the active pharmaceutical ingredient (API) over an extended period, ensuring that the drug is released gradually and consistently for optimal therapeutic effects.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Developing Moisture Barrier Coatings for Capsules – V 2.0

Posted on By

The purpose of this SOP is to outline the process for developing moisture barrier coatings for capsules to protect the fill material from environmental conditions such as moisture and humidity. The barrier ensures that the capsules maintain their integrity, stability, and performance throughout their shelf life.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Process Optimization of Capsule Sealing – V 2.0

Posted on By

The purpose of this SOP is to define the procedure for optimizing the capsule sealing process to ensure uniform, efficient, and secure sealing of capsules. Proper sealing is crucial for preventing content leakage, ensuring product integrity, and enhancing shelf life.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Encapsulation Trials Using New Fill Materials – V 2.0

Posted on By

The purpose of this SOP is to define the procedure for conducting encapsulation trials using new fill materials. Encapsulation trials are essential for ensuring the compatibility of new fill materials with the capsule manufacturing process, as well as verifying that the material can be encapsulated effectively while maintaining the quality of the final product.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Selection of Capsule Size for Formulations – V 2.0

Posted on By

The purpose of this SOP is to establish the procedure for selecting the appropriate capsule size for different formulations. The goal is to ensure that the selected capsule size accommodates the required dose, ensuring both the stability and ease of administration of the final product.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Stability Studies During Formulation Development – V 2.0

Posted on By

The purpose of this SOP is to define the procedure for conducting stability studies during capsule formulation development. Stability testing ensures that the developed formulation maintains its intended quality, safety, and efficacy over time under various environmental conditions.

Click to read the full article.

Capsules V 2.0

Capsule: SOP for Preparing Development Reports for Capsule Dosage Forms – V 2.0

Posted on By

The purpose of this SOP is to outline the procedure for preparing development reports for capsule dosage forms. These reports are critical for documenting the formulation, development process, and testing results, ensuring that the capsules meet all required specifications for efficacy, safety, and stability.

Click to read the full article.

Capsules V 2.0

Posts pagination

Previous 1 … 18 19 20 … 23 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme